Roberta Gualtierotti: Point-of-Care SPR Device for Rapid Detection of Anti-PEG Antibodies
Roberta Gualtierotti, Associate Professor of Internal Medicine at the University of Milan, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in scientific reports, nature, adding:
“Excited to share this new work on a point-of-care SPR device for rapid detection of anti-PEG antibodies by Laura Pasquardini et al
PEGylation is widely used in biologic drugs, including extended half-life FVIII products for hemophilia A, to improve safety and efficacy.
However, PEG itself may trigger anti-PEG antibodies, potentially causing loss of treatment efficacy.
Our study presents a portable, low-cost platform capable of detecting anti-PEG IgG and IgM in just 15 minutes from human plasma, with nanomolar sensitivity and strong agreement with other methods (SPR and ELISA).
A step forward toward personalized monitoring of PEG immunogenicity and safer use of PEGylated therapies.”
Title: Development of a portable device for the detection of anti-PEG antibodies in human plasma
Authors: Laura Pasquardini, Nunzio Cennamo, Camilla Rossi, Roberto Canteri, Lia Vanzetti, Marten Beeg, Roberta Gualtierotti, Luca Pasquale Renzullo, Ines Tavoletta, Lucia Schiavone, Carla Valsecchi, Chiara Suffritti, Flora Peyvandi, Marco Gobbi, Luigi Zeni
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 23, 2026, 04:34David Akande: When Sickle Cell Crises Have No Clear Trigger
-
Sep 23, 2026, 04:13Jean Connors: Safety of Heparin Re-Exposure in Patients with Remote HIT
-
Sep 23, 2026, 04:09Beth Psaila: Applications Now Open for the Gordon Research Conference on Megakaryocytes and Platelets
-
Sep 23, 2026, 03:27Abbie Newton: How Better Data Can Reduce Platelet Wastage
-
Sep 23, 2026, 03:01Suvro Sankha Datta: Rapid Blood Group Genotyping Using Gold Oligo Nanonet Assembly
-
Sep 23, 2026, 02:55Asghar Muhammad: Exploring New Ways to Expand Blood Transfusion Compatibility
-
Sep 23, 2026, 02:49Bianca Rocca: Personalized Cardiovascular Pharmacotherapy in the September 2026 EHJ Issue
-
Sep 23, 2026, 02:35Udaya RajBhandari: A Hidden Risk of Repeated Transfusions in β Thalassemia
-
Sep 23, 2026, 00:08Janar Sathananthan: The Importance of Durable Drug Delivery in DCB Therapy